Method for inhibiting myocardial fibrosis by administering an aldosterone antagonist which suppresses aldoster one receptors

摘要

This invention discloses a method of using an aldosterone antagonist such as spironolactone, at a dosage which does not disrupt a patient's normal electrolyte and water-retention balance, to inhibit myocardial fibrosis, including left ventricular hypertrophy (LVH).